These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31199966)

  • 41. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Bemelmans BL
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
    MacDiarmid S; Staskin DR; Lucente V; Kaaki B; English S; Gilling P; Meffan P; Clark M; Sand PK; Sen SK; Rovner E
    J Urol; 2019 May; 201(5):967-972. PubMed ID: 31009968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Thiery E
    Urology; 2016 Aug; 94():57-63. PubMed ID: 27131966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
    Yune JJ; Shen JK; Pierce MA; Hardesty JS; Kim J; Siddighi S
    Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
    Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
    Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
    Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder.
    Zhang Y; Meng L; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
    Transl Androl Urol; 2021 May; 10(5):1966-1975. PubMed ID: 34159077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcutaneous medial plantar nerve stimulation in women with idiopathic overactive bladder.
    Yildiz N; Sonmez R
    Investig Clin Urol; 2023 Jul; 64(4):395-403. PubMed ID: 37417565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder.
    Siegel S; Noblett K; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Berg KC; Kan F; Irwin CP
    Neurourol Urodyn; 2015 Mar; 34(3):224-30. PubMed ID: 24415559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pilot Study of a Novel At-Home Posterior Tibial Nerve System for Overactive Bladder Syndrome.
    Burton CS; Sokol ER
    Urogynecology (Phila); 2024 Feb; 30(2):107-113. PubMed ID: 37493289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
    Gilling P; Meffan P; Kaaki B; MacDiarmid S; Lucente V; Clark M; Sen SK; English S; Sand PK
    Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate and continued results of parasacral transcutaneous electrical nerve stimulation in paediatric patients with overactive bladders.
    Michal M; Agata LG; Katarzyna J; Ilona C; Andrzej G; Aleksandra Ż
    J Pediatr Urol; 2024 Oct; 20(5):868-876. PubMed ID: 39069460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parasacral transcutaneous electrical neural stimulation (PTENS) once a week for the treatment of overactive bladder in children: A randomized controlled trial.
    de Paula LIDS; de Oliveira LF; Cruz BP; de Oliveira DM; Miranda LM; de Moraes Ribeiro M; Duque RO; de Figueiredo AA; de Bessa J; Netto JMB
    J Pediatr Urol; 2017 Jun; 13(3):263.e1-263.e6. PubMed ID: 28089606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence.
    Kaaki B; English S; Gilling P; Meffan P; Lucente V; MacDiarmid S; Clark M; Sen SK
    Female Pelvic Med Reconstr Surg; 2022 May; 28(5):287-292. PubMed ID: 35536667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.